These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 26635361)

  • 1. Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome.
    Mjelva ØR; Pönitz V; Brügger-Andersen T; Grundt H; Staines H; Nilsen DW
    Eur J Prev Cardiol; 2016 Jul; 23(11):1130-40. PubMed ID: 26635361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain.
    Brügger-Andersen T; Pönitz V; Kontny F; Staines H; Grundt H; Sagara M; Nilsen DW
    Thromb Haemost; 2009 Sep; 102(3):555-63. PubMed ID: 19718477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study.
    Brügger-Andersen T; Pönitz V; Staines H; Pritchard D; Grundt H; Nilsen DW
    BMC Cardiovasc Disord; 2008 Nov; 8():34. PubMed ID: 19032759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
    Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R
    BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, Argentina.
    León de la Fuente R; Naesgaard PA; Nilsen ST; Woie L; Aarsland T; Gallo P; Grundt H; Staines H; Nilsen DW
    BMC Cardiovasc Disord; 2011 Sep; 11():57. PubMed ID: 21958326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score.
    Klingenberg R; Aghlmandi S; Räber L; Gencer B; Nanchen D; Heg D; Carballo S; Rodondi N; Mach F; Windecker S; Jüni P; von Eckardstein A; Matter CM; Lüscher TF
    Eur Heart J Acute Cardiovasc Care; 2018 Mar; 7(2):129-138. PubMed ID: 28029055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome.
    Eggers KM; Armstrong PW; Califf RM; Johnston N; Simoons ML; Venge P; James SK
    Clin Biochem; 2013 Nov; 46(16-17):1655-9. PubMed ID: 24012697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
    Lindholm D; James SK; Gabrysch K; Storey RF; Himmelmann A; Cannon CP; Mahaffey KW; Steg PG; Held C; Siegbahn A; Wallentin L
    JAMA Cardiol; 2018 Dec; 3(12):1160-1166. PubMed ID: 30427997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention].
    He B; Ding S; Pu J; Liu JP; Song W; Du YP; Shen JY; Jin SX; Sun Y; Shen L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):349-52. PubMed ID: 16776932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction.
    Matsui S; Ishii J; Kitagawa F; Kuno A; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Naruse H; Tanaka I; Nomura M; Hishida H; Ozaki Y
    Atherosclerosis; 2010 May; 210(1):220-5. PubMed ID: 19945702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
    Latini R; Maggioni AP; Peri G; Gonzini L; Lucci D; Mocarelli P; Vago L; Pasqualini F; Signorini S; Soldateschi D; Tarli L; Schweiger C; Fresco C; Cecere R; Tognoni G; Mantovani A;
    Circulation; 2004 Oct; 110(16):2349-54. PubMed ID: 15477419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very Long-Term Prognostic Role of Admission BNP in Non-ST Segment Elevation Acute Coronary Syndrome.
    Bassan F; Bassan R; Esporcatte R; Santos B; Tura B
    Arq Bras Cardiol; 2016 Mar; 106(3):218-25. PubMed ID: 26840056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of pentraxin-3 and galectin-3 in acute coronary syndrome: a short-term prospective cohort study.
    George M; Shanmugam E; Srivatsan V; Vasanth K; Ramraj B; Rajaram M; Jena A; Sridhar A; Chaudhury M; Kaliappan I
    Ther Adv Cardiovasc Dis; 2015 Oct; 9(5):275-84. PubMed ID: 25814534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic utility of D-dimer and fibrin monomer at long-term follow-up after hospitalization with coronary chest pain.
    Brügger-Andersen T; Pönitz V; Staines H; Grundt H; Hetland Ø; Nilsen DW
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):701-7. PubMed ID: 18832914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach: the North Wuerttemberg and Berlin Infarction Study-II (NOBIS-II).
    Möckel M; Müller R; Vollert J; Müller C; Danne O; Gareis R; Störk T; Dietz R; Koenig W
    Clin Res Cardiol; 2007 Sep; 96(9):604-12. PubMed ID: 17593313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death.
    Scirica BM; Cannon CP; Sabatine MS; Jarolim P; Sloane S; Rifai N; Braunwald E; Morrow DA;
    Clin Chem; 2009 Feb; 55(2):265-73. PubMed ID: 19074516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide in the early diagnosis and risk stratification of acute chest pain.
    Haaf P; Reichlin T; Corson N; Twerenbold R; Reiter M; Steuer S; Bassetti S; Winkler K; Stelzig C; Heinisch C; Drexler B; Freidank H; Mueller C
    Am J Med; 2011 May; 124(5):444-52. PubMed ID: 21531234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognostic significance of pentraxin-3 in patients with acute myocardial infarction: 5-year prospective cohort study.
    Altay S; Çakmak HA; Kemaloğlu Öz T; Özpamuk Karadeniz F; Türer A; Erer HB; Kılıç GF; Keleş İ; Can G; Eren M
    Anatol J Cardiol; 2017 Mar; 17(3):202-209. PubMed ID: 27488759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial.
    Kontny F; Andersen T; Ueland T; Åkerblom A; Lakic TG; Michelsen AE; Aukrust P; Bertilsson M; Becker RC; Himmelmann A; James SK; Siegbahn A; Storey RF; Wallentin L;
    Eur Heart J Acute Cardiovasc Care; 2020 Jun; 9(4):313-322. PubMed ID: 31017470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.